Merit Financial Group’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.5M | Buy |
134,928
+14,508
| +12% | +$1.56M | 0.16% | 103 |
|
|
2025
Q1 | $12.1M | Buy |
120,420
+12,938
| +12% | +$1.31M | 0.18% | 94 |
|
|
2024
Q4 | $9.6M | Buy |
107,482
+11,502
| +12% | +$1.03M | 0.17% | 114 |
|
|
2024
Q3 | $8.04M | Sell |
95,980
-9,639
| -9% | -$808K | 0.18% | 100 |
|
|
2024
Q2 | $8.13M | Buy |
105,619
+4,204
| +4% | +$324K | 0.18% | 95 |
|
|
2024
Q1 | $7.39M | Buy |
101,415
+9,141
| +10% | +$666K | 0.18% | 99 |
|
|
2023
Q4 | $5.33M | Buy |
92,274
+7,162
| +8% | +$414K | 0.16% | 92 |
|
|
2023
Q3 | $4.49M | Sell |
85,112
-10,224
| -11% | -$540K | 0.15% | 109 |
|
|
2023
Q2 | $5.16M | Buy |
95,336
+2,630
| +3% | +$142K | 0.17% | 96 |
|
|
2023
Q1 | $4.64M | Buy |
92,706
+2,096
| +2% | +$105K | 0.17% | 91 |
|
|
2022
Q4 | $4.19M | Buy |
90,610
+18,745
| +26% | +$867K | 0.15% | 99 |
|
|
2022
Q3 | $2.78M | Buy |
+71,865
| New | +$2.78M | 0.12% | 119 |
|
|
2020
Q1 | – | Sell |
-5,263
| Closed | -$238K | – | 223 |
|
|
2019
Q4 | $238K | Buy |
+5,263
| New | +$238K | 0.02% | 211 |
|